Immuron Plans Phase 2 Trial for IMM-529 following FDA review
IMRN Stock | USD 2.16 0.15 7.46% |
About 54% of Immuron's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Immuron Ltd ADR suggests that some traders are interested. Immuron's investing sentiment overview a quick insight into current market opportunities from investing in Immuron Ltd ADR. Many technical investors use Immuron Ltd ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Immuron |
Key Points Immuron completes pre-IND meeting with FDA on the development of IMM-529 as product to specifically prevent or treat Clostridioides difficile...
Read at globenewswire.com
Immuron Fundamental Analysis
We analyze Immuron's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immuron using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immuron based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Immuron is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Immuron Ltd ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immuron stock to make a market-neutral strategy. Peer analysis of Immuron could also be used in its relative valuation, which is a method of valuing Immuron by comparing valuation metrics with similar companies.
Peers
Immuron Related Equities
ADXN | Addex Therapeutics | 5.34 | ||||
INAB | In8bio | 4.00 | ||||
IPHA | Innate Pharma | 1.70 | ||||
DYAI | Dyadic International | 1.36 | ||||
TCRX | Tscan Therapeutics | 0.39 | ||||
IMMX | Immix Biopharma | 1.52 | ||||
APM | Aptorum Group | 5.69 | ||||
PHIO | Phio Pharmaceuticals | 7.21 |
Check out Immuron Hype Analysis, Immuron Correlation and Immuron Performance. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immuron. If investors know Immuron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immuron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immuron Ltd ADR is measured differently than its book value, which is the value of Immuron that is recorded on the company's balance sheet. Investors also form their own opinion of Immuron's value that differs from its market value or its book value, called intrinsic value, which is Immuron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immuron's market value can be influenced by many factors that don't directly affect Immuron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immuron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.